UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Margrit Carlson, MD

Print
Email

Margrit Carlson, MD

UCLA Physician Margrit Carlson, MD specializes in Infectious Disease.
Specialty
Infectious Disease
Gender
Female
Language Spoken
English
Hospital Affiliation
Ronald Reagan UCLA Medical Center
State License Number
G73936
Contact
(310) 557-2273 Information and referral
Fax Number
(310) 557-3450
Voted Super Doctor
PRACTICE LOCATION

UCLA CARE Clinic
1399 S Roxbury Dr., Suite 100
Los Angeles CA 90035

MEDICAL BOARD CERTIFICATION
Infectious Disease, American Board of Internal Medicine, 1996, 2006
Internal Medicine, American Board of Internal Medicine, 1993, 2004
EDUCATION
Fellowship
Medicine/Infectious Disease, UCLA School of Medicine, 1993 - 1996
Residency
Internal Medicine, UCLA School of Medicine, 1991 - 1993
Internship
Internal Medicine, UCLA School of Medicine, 1990 - 1991
Degree
MD, George Washington University School of Medicine, 1990
CLINICAL INTEREST
AIDS, HIV, Transplant Infectious Diseases
AFFILIATION
Department Affiliation
Provider, CARE Center, Infectious Diseases
MORE INFORMATION
Additional Information
Dr. Carlson is currently conducting a variety of clinical trials through the Center for Clinical AIDS Research and Education. She is the medical director of the CARE Clinic and is responsible for the primary care of HIV infected adults, as well as the education of housestaff in HIV care both at UCLA and a community-based clinic. She is also a consultant on the inpatient general infectious disease service as well as the solid organ transplantation infectious disease service. Her research interests include the neurologic complications of HIV, novel therapies, and treatment of drug resistant HIV infection.
Publications

Selected Recent Publications

  1. Jabs DA, Gilpin AM, Min YI, et al. Studies of Ocular Complications of AIDS Research Group. HIV and CMV viral load and clinical outcomes in AIDS and CMV Retinitis patients: Monoclonal Antibody CMV Retinitis Trial. AIDS 2002;16:877-887.
  2. Kilby J, Lalezari J, Eron J, Carlson, M, et al. Safety, Plasma Pharmacokinetics And Antiviral Activity of Subcutaneous T-20, A Peptide Inhibitor Of gp41-Mediated Infusion, In HIV Infected Adults. AIDS Research Human Retroviruses 2002;18:685-693.
  3. Holbrook, Janet et al. Visual Loss in Patients with CMV Retinitis and AIDS before Widespread Availability of Highly Active Antiretroviral Therapy. Archives of Ophthalmology 2003;121:99-107.
  4. Lalezari J, Eron J, Carlson M, et al. A Phase II clinical study of the long –term safety and antiviral activity of enfurtide-based antiretroviral therapy. AIDS 2003;17:691-698.
  5. Lalezari J, DeJesus E, Northfelt D, Richmond, Wolfe P, Haubrich R, Henry D, Powderly W, Becker S, Thompson M, Valentine F, Wright D, Carlson M, Riddler S, Haas F, DeMasi R, Sista P, Salgo M, Delehanty J. A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naïve HIV-infected adults. Antiviral Therapy, 2003:8(4) 279-287.
  6. Gulick, Roy et al for the AIDS Clinical Trials Group Study A5095 Team. Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the initial Treatment of HIV-1 Infection. NEJM 2004; 350:1850-61.
  7. Gulick; Roy; Ribaudo H; Shikuma, C; Lalama, C; Schackman,B ; Meyer, W; Acosta,E; Schouten,J;Squires, K; Pilcher, C; Murphy.R; Koletar, S; Carlson, M; Reichman, R; Bastow, B; Klingman, K; Kuritzkes, D; for the AIDS Clinical Trials Group (ACTG) A5095 Study Team Three- vs Four-Drug Antiretroviral Regimens for the Initial Treatment of HIV-1 Infection: A Randomized Controlled Trial JAMA. 2006;296:769-781.

Link to my pubmed publications »

Back to top
Referring a Patient to UCLA
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.

Find out how to refer a patient
Margrit Carlson, click here to update your profile.